Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2019-05-15 2019-05-14
Drug Identification Number 02410303 02410303
Brand name MOVISSE MOVISSE
Common or Proper name NORETHINDRONE NORETHINDRONE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients NORETHINDRONE NORETHINDRONE
Strength(s) 0.35MG 0.35MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28BL 28BL
ATC code G03AC G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-05-14 2019-05-14
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments